Αποτελέσματα Αναζήτησης
ORTHO EVRA ® is a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN) and 0.75 mg ethinyl estradiol (EE). Systemic...
A combination of fexofenadine HCl and pseudoephedrine HCl in an extended-re-lease tablet (60 mg/120 mg) is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and chil-dren 12 years and older. For more infor-mation, contact Barr Pharmaceuticals Inc. by calling 800-222-0190 or 201-930-3302.
1. NAME OF THE MEDICINAL PRODUCT. EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each 20 cm2 transdermal patch contains 6 mg norelgestromin (NGMN) and 600 micrograms ethinyl estradiol (EE).
Overview. This is a summary of the European public assessment report (EPAR) for Evra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Evra.
16 Μαΐ 2010 · Norelgestromin is the active progestin responsible for the progestational activity that occurs in women after application of ORTHO EVRA patch. Type Small Molecule
15 Ιαν 2024 · Ortho Evra is a contraceptive skin patch containing a combination of female hormones (ethinyl estradiol and norelgestromin) that prevent ovulation (the release of an egg from an ovary).
30 Δεκ 2023 · Generic name: ethinyl estradiol and norelgestromin [ nor-el-JES-troe-min, ETH-i-nil-es-tra-DYE-ol ] Brand names: Ortho Evra, Xulane Drug class: Contraceptives. Medically reviewed by Drugs.com. Last updated on Dec 30, 2023. Uses. Before taking. Dosage. Warnings. Side effects. Brand names. FAQ.
